At the Opening Bell on November 25, the Sensex stood at a value of 84,802.58, recording a decline of 98.13 points, or 0.12%. Similarly, the Nifty was recorded at 25,933.95, down by 25.55 points, representing a marginal fall of 0.10%.
In contrast, the Indian Rupee strengthened, opening higher at ₹89.06 per dollar, which was an appreciation of ₹0.17 paise. The overall market breadth showed a slight edge for gainers, with 1076 shares advancing, 1020 shares declining, and 186 shares remaining unchanged.
Source: NSE, BSE, and DGFT (As of 9.16 AM, November 25, 2025)
Top Movers This Morning
| Company Name | Current Price (₹) | Price Change (₹) |
| Craftsman Automation | 6,970 | 310.00 |
| Neuland Labs | 16,410 | 127.00 |
| Apar Industries | 8,976 | 83.50 |
| Data Patterns (India) | 3,016 | 75.10 |
| Maruti Suzuki | 16,030 | 72.00 |
Note: The Price is as of 10.18 AM, November 25, 2025.
Top News This Morning
- US Rate Cut Hopes: Global equity markets are lifted by expectations of a 25 basis point rate cut from the US Federal Reserve.
- FIIs Dump Cash: Continued heavy selling by Foreign Institutional Investors remains a major headwind for the Indian indices.
- Glenmark’s COPD Innovation: Launch of the world’s first nebulised triple therapy for COPD marks a significant development in the pharma sector.
- Central Bank Hints at Possible Rate Reduction: Reserve Bank of India (RBI) Governor Sanjay Malhotra recently suggested that there is potential flexibility for a rate cut during the upcoming policy review. In light of continuously subdued inflation figures, analysts at Morgan Stanley anticipate a 25 basis-point reduction. The definitive interest rate decision is scheduled to be finalised at the Monetary Policy Committee (MPC) meeting, set to take place between December 3rd and 5th.
- Infrastructure Boom: Major work orders across power transmission and highway construction signal strong activity in the infrastructure sector.
Source: Moneycontrol
Global Cues and Foreign Investor Action
- Positive Signals: Rallies in US markets and anticipation of a 25 basis point rate cut from the US Federal Reserve are broadly favourable for global equities.
- FII Selling: The attempted break of the Nifty’s September 2024 high is being resisted primarily by renewed selling from Foreign Institutional Investors (FIIs), which amounted to a significant ₹4171 crores in the cash market yesterday.
Source: Moneycontrol
Corporate and Sector News Highlights
- Pharma Breakthrough: Glenmark Pharmaceuticals launched Nebzmart GFB Smartules and Glenmark Airz FB Smartules, the world’s first nebulised, fixed-dose triple therapy for Chronic Obstructive Pulmonary Disease (COPD), offering an easier alternative to conventional inhalers.
- Acquisition and Stake Buy: Eris Lifesciences is set to acquire the remaining 30% stake in its subsidiary, Swiss Parenterals, for ₹423.3 crore.
- Infrastructure Orders: Diamond Power Infrastructure secured a ₹276.05 crore Letter of Intent from Adani Energy Solutions. Ceigall India also received a Letter of Intent for a substation establishment.
Source: Moneycontrol
Bottomline
Despite the tailwinds from positive global signals, particularly the hopes for a US rate cut, the Indian indices (Nifty and Sensex) faced immediate resistance at the Opening Bell.
This cautious sentiment was primarily driven by aggressive selling from Foreign Institutional Investors (FIIs), amounting to ₹4171 crores yesterday. While the Rupee showed strength and sectors like Pharma and Infrastructure announced significant deals and innovations (like Glenmark’s COPD breakthrough), the market’s immediate trajectory remains contingent on whether domestic buying can absorb the sustained FII outflow and push the Nifty past its key resistance levels.
Disclaimer: Investments in the securities market are subject to market risks, read all the related documents carefully before investing. This content is purely for information purpose only and in no way to be considered as an advice or recommendation. The securities are quoted as an example and not as a recommendation.
Investors are requested to do their own due diligence before investing. Paytm Money Ltd SEBI Reg No. Broking – INZ000240532, Depository Participant – IN – DP – 416 – 2019, Depository Participant Number: CDSL – 12088800, NSE (90165), BSE (6707) Regd Office: 136, 1st Floor, Devika Tower, Nehru Place, Delhi – 110019. For complete Terms & Conditions and Disclaimers visit: https://www.paytmmoney.com/stocks/policies/terms .
